Buy Aminazine ampoules 2.5% 2ml №10
  • Buy Aminazine ampoules 2.5% 2ml №10

Aminazine ampoules 2.5% 2ml №10

$14.94
Quantity

  • All payments are encrypted via SSL All payments are encrypted via SSL
  • Full Refund if you haven't received your order Full Refund if you haven't received your order

Active ingredient and dosage form

Aminazine solution for in / in and / m introduction
1 ml of solution contains chlorpromazine 25 mg;
10 vials of 2 ml per pack.

Aminazine dragee
1 dragee contains chlorpromazine hydrochloride 25, 50 or 100 mg;
10 pieces. packaged.

Mechanism of action

Aminazine is an antipsychotic (neuroleptic) from the group of phenothiazine derivatives. It has a pronounced antipsychotic, sedative, antiemetic effect. Aminazine weakens or completely eliminates delusions and hallucinations, suppresses psychomotor agitation, reduces affective reactions, anxiety, anxiety, lowers physical activity. The mechanism of antipsychotic action is associated with the blockade of postsynaptic dopaminergic receptors in the mesolimbic structures of the brain. Aminazine also has a blocking effect on α-adrenoreceptors and suppresses the release of pituitary and hypothalamic hormones. However, the blockade of dopamine receptors increases the secretion of prolactin by the pituitary gland.

Indications and usage

Chronic paranoid and hallucinatory-paranoid states, states of psychomotor agitation in schizophrenia (hallucinatory-delusional, hebephrenic, catatonic syndromes), alcoholic psychosis, manic arousal in manic-depressive psychosis, mental disorders in epilepsy, agitated depression in patients with presenile psychosis, manic-depressive psychosis, as well as in other diseases accompanied by arousal, tension. Neurotic diseases accompanied by increased muscle tone. Persistent pain, incl. causalgia (in combination with analgesics), persistent sleep disorders (in combination with hypnotics and tranquilizers). Meniere's disease, pregnant vomiting, treatment and prevention of vomiting in the treatment of antitumor agents and during radiation therapy. Itchy dermatosis. As part of "lytic mixtures" in anesthesiology..

Dosage and administration

Installed individually. When ingested for adults, a single dose of Aminazine is 10-100 mg, a daily dose is 25-600 mg; for children aged 1-5 years - 500 mcg / kg every 4-6 hours, for children older than 5 years, you can apply 1 / 3-1 / 2 adult doses.

With the / m or / in the introduction for adults, the initial dose - 25-50 mg. With the / m or / in the introduction of children older than 1 year, a single dose of 250-500 mg / kg. The frequency of use of Aminazine inside or parenterally depends on the evidence and the clinical situation.

Contraindications

Violations of the liver, kidneys, blood-forming organs, progressive systemic diseases of the brain and spinal cord, myxedema, severe cardiovascular diseases, thromboembolic disease; late stage bronchiectasis; angle-closure glaucoma; urinary retention associated with prostatic hyperplasia; pronounced depression of the central nervous system, coma, brain injury.

Adverse reactions

From the side of the central nervous system: possible akathisia, blurred vision; rarely - dystonic extrapyramidal reactions, parkinson syndrome, tardive dyskinesia, disturbances of thermoregulation, MNS; in isolated cases - seizures.
Since the cardiovascular system: possible hypotension (especially with a / in the introduction), tachycardia.
On the part of the digestive system: dyspeptic phenomena are possible (by ingestion); rarely - cholestatic jaundice.
On the part of the blood system: rarely - leukopenia, agranulocytosis.
From the urinary system: rarely - difficulty urinating.
On the part of the endocrine system: menstrual disorders, impotence, gynecomastia, weight gain.
Allergic reactions: skin rash, itching; rarely - exfoliative dermatitis, erythema multiforme.
Dermatological reactions: rarely - skin pigmentation, photosensitivity.
On the part of the organ of vision: with prolonged use in high doses, chlorpromazine may be deposited in the anterior structures of the eye (cornea and lens), which may accelerate the normal aging of the lens.

Pregnancy and Breastfeeding

If necessary, the use of chlorpromazine during pregnancy should limit the treatment time, and at the end of pregnancy, if possible, reduce the dose. It should be borne in mind that chlorpromazine prolongs labor.
If necessary, use during lactation breastfeeding should be discontinued.

Special notes

With particular caution, phenothiazines are used in patients with pathological changes in the blood picture, in disorders of liver function, alcohol intoxication, Reye's syndrome, as well as in breast cancer, cardiovascular diseases, susceptibility to the development of glaucoma, Parkinson's disease, gastric ulcer and duodenal ulcer., urinary retention, chronic diseases of the respiratory system (especially in children), epileptic seizures. Aminazine should be used with caution in elderly patients (increased risk of excessive sedative and hypotensive action), in exhausted and weakened patients.

Storage conditions

Store in a dry, dark place and out of reach of children, at a temperature not exceeding 25 ° C.

Aminazine